By Kiran Mazumdar-Shaw It was very heartening to see a Budget empathize with those who had to bear adverse health effects of the pandemic. The wide coverage of our nation’s vaccination drive greatly helped amidst the 3rd wave of the pandemic caused by the Omicron variant, resulting in milder symptoms. Even though India is in … Continue reading Budget: Taking Strides Towards Digital Health
A Fair Budget that Balances the Needs of the Indian Economy
By Kiran Mazumdar-Shaw Finance Minister Nirmala Sitharaman has presented the nation with a balanced Budget for FY23. The Indian economy needs a steadying hand at a time when it is trying to find its feet as the tremors from the global COVID-19 pandemic recede slowly. She has prudently laid the groundwork for a gradual economic … Continue reading A Fair Budget that Balances the Needs of the Indian Economy
A Balanced Budget
By Kiran Mazumdar Shaw, Chairperson, Biocon Finance Minister Nirmala Sitharaman has delivered a Budget that ticks several boxes. The Budget focused on maintaining fiscal prudence, improving ease of doing business, boosting infrastructure, and creating a strong digital governance architecture. The economic gloom caused by the Covid-19 pandemic had raised expectations of a ‘feel good’ budget. … Continue reading A Balanced Budget
HOPE FM DELIVERS A FEEL-GOOD BUDGET
By Kiran Mazumdar-Shaw The Covid-19 pandemic has cast a gloomy outlook across the entire economy. Government coffers are depleting, Industry investments are shrinking, and citizens are being hit by inflation and job losses. Budget 2022 is an event that everyone is hoping will deliver good news and I wish the Finance Minister will not dash our hopes! … Continue reading HOPE FM DELIVERS A FEEL-GOOD BUDGET
Budget Offers an Opportunity To Strengthen India’s R&D and Innovation Ecosystem
By Kiran Mazumdar-Shaw The Indian pharmaceutical industry has been playing a key role in improving global health through its affordable and high-quality generic medicines. We are the third largest pharmaceuticals supplier in terms of volume, supplying 60,000 generic brands across 60 therapeutic categories worldwide. India now needs to capture value share as well. To move … Continue reading Budget Offers an Opportunity To Strengthen India’s R&D and Innovation Ecosystem